IQVIA Holdings Inc.

NYSE:IQV

Medical - Diagnostics & Research

Healthcare
$257.84 -1.83%

-$3.13 today

Market cap
$42.49B
Beta
1.22
P/E (TTM)
20.4
EPS (TTM)
$8.22
52W Low $153.01High $247.05

Volume 1.40M

Average 1.62M

IQV Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

IQVIA Holdings Inc.NYSE: IQV

Accounts Payables · Q2 FY2026 · quarter ended Jun 2026

Accounts payables outflow grows to $0

Q2 FY2026 accounts payables was $0, compared with $0 a year earlier. Trailing-twelve-month accounts payables was $0.

Context

  • Accounts payables amounted to 0.6% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Accounts payables increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts payables holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
-$96M-183.5% YoY
LTMJun 2026
$0— YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-183.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
(96M) USD
Year-over-year change
-183.5%

Accounts Payables vs competitors

How IQV compares with its peers on the latest reported figures

  • IQV's LTM Jun 2026 accounts payables of $0 is the 8th largest of the 9 companies compared; the peer median is $2.43M.
  • Accounts payables amounts to 0.0% of revenue for IQV, versus a peer median of 0.1%.
IQV Competitors Peer median
Accounts Payables for IQV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FTREFortrea Holdings Inc.LTM Jun 2026$38.5M -26.8%—1.4%
TEMTempus AI, Inc.LTM Sep 2026$11.29M +164.1%-2.9%0.7%
CERTCertara, Inc.LTM Mar 2026$10.67M +138.4%—2.5%
CRLCharles River Laboratories International, Inc.LTM Jun 2026$7.9M -6.0%—0.2%
MEDPMedpace Holdings, Inc.LTM Sep 2026$2.8M +106.0%-25.8%0.1%
VEEVVeeva Systems Inc.LTM Jul 2026$2.07M -56.4%-34.3%0.1%
HCATHealth Catalyst, Inc.LTM Mar 2026$91K -97.7%+34.8%0.0%
IQVIQVIA Holdings Inc.LTM Jun 2026$0 ——0.0%
ICLRICON Public Limited CompanyLTM Jun 2026$0 ——0.0%
Peer median (excluding IQV) $2.43M-6.0%-14.4%0.1%

Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income966M1.09B1.36B1.37B1.36B
Depreciation & Amortization1.26B1.13B1.13B1.11B1.14B
Deferred Income Tax(138M)(115M)(269M)(129M)(180M)
Stock-Based Compensation170M194M217M206M247M
Change in Working Capital680M(84M)(280M)158M125M
Accounts Receivables(138M)(421M)(388M)182M60M
Inventory00000
Accounts Payables244M427M267M115M(96M)
Other Working Capital574M(90M)(159M)(139M)161M
Other Non-Cash Items044M(2M)(6M)(43M)
Operating Cash Flow2.94B2.26B2.15B2.72B2.65B
Capital Expenditures(640M)(674M)(649M)(602M)(603M)
Acquisitions (Net)(1.46B)(1.34B)(876M)(710M)(1.76B)
Purchases of Investments(15M)(5M)(83M)(134M)(20M)
Sales of Investments5M0002M
Other Investing Activities5M8M5M2M74M
Investing Cash Flow(2.1B)(2.01B)(1.6B)(1.44B)(2.31B)
Debt Repayment70M941M802M553M1.21B
Common Stock Issued0000(67M)
Common Stock Repurchased(406M)(1.17B)(992M)(1.35B)(1.24B)
Dividends Paid00000
Other Financing Activities(899M)(102M)(192M)(81M)(44M)
Financing Cash Flow(1.24B)(329M)(382M)(878M)(150M)
Effect of Forex Changes(52M)(75M)(4M)(68M)79M
Net Change in Cash(448M)(150M)160M326M278M
Free Cash Flow2.3B1.59B1.5B2.11B2.05B

IQVIA Holdings Inc.

NYSE:IQV

Intrinsic Alpha fair value

Locked

Current Price

$257.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.